Aantal gebruikers 2020-2024 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| J05AF01 Zidovudine (Retrovir ®) | 14 | 19 | 25 | 13 | 13 |
| J05AF05 Lamivudine (Zeffix ®) | 565 | 474 | 441 | 360 | 294 |
| J05AF06 Abacavir (Ziagen ®) | 184 | 151 | 121 | 101 | 73 |
| J05AF07 Tenofovirdisoproxil (Viread ®) | 2.187 | 2.168 | 2.241 | 2.268 | 2.295 |
| J05AF08 Adefovir | 51 | 43 | 33 | 24 | . |
| J05AF09 Emtricitabine (Emtriva ®) | 34 | 35 | 34 | 33 | 22 |
| J05AF10 Entecavir (Baraclude ®) | 2.078 | 2.176 | 2.278 | 2.483 | 2.689 |
| J05AF11 Telbivudine | 2 | . | . | . | . |
| J05AF13 Tenofoviralafenamide (Vemlidy ®) | 527 | 564 | 636 | 724 | 756 |